An assistant professor discusses AI's evolution from a buzzw

Paul Craig developed a program that helps educators develop engaging courses that empower students and allow them to engage in hands-on scientific research.

MOSAIC scholar Stanna Dorn uses total synthesis to recreate rare bacterial natural products with potential therapeutic applications.

WASHINGTON — The National Academy of Sciences announced today the election of 120 members and 30 international members in recognition of their distinguished and continuing achievements in original res...

Learn about the candidates running for ASBMB President, Secretary, Councilor, Nominating Committee and Publications Committee.

Learn how the JBC associate editor went from milking cows on a dairy farm to analyzing kinases in the lab.

He was an associate professor of biochemistry at the University of Colorado Boulder and co-founder of the biotech company Prometheus Materials.

May 12 is the early registration and oral abstract deadline for ASBMB's meeting on O-GlcNAcylation.

Scientists develop a software tool to categorize microbe species and antibiotic resistance markers to aid clinical and environmental research. Read about this recent article published in Molecular &...

Researchers analyze protein and RNA data across 13 cancer types to find similarities that could improve cancer staging, prognosis and treatment strategies. Read about this recent article published in Molecular & Cellular Proteomics.

Scientists discover that triacylglycerol synthesis enzyme drives lipoproteins secretion rather than lipid droplet storage. Read more about this recent study from the Journal of Biological Chemistry.

Recent lipid metabolism research has unveiled critical insights into lipid–protein interactions, offering potential therapeutic targets for metabolic and neurodegenerative diseases. Check out the latest in lipid science at the ASBMB annual meeting.

Learn about the ASBMB 2025 symposium on oncogenic hubs: chromatin regulatory and transcriptional complexes in cancer.

Induced pluripotent stem cells are paving the way for personalized treatments to diabetes, vision loss and more. However, scientists still face hurdles such as strict regulations, scalability, cell lo...

Learn about the ASBMB 2025 symposium on synthetic biology, featuring applications to better human and environmental health.

Learn about the ASBMB 2025 symposium on host–pathogen interactions, to be held Sunday, April 13 at 1:50 p.m.

A microfluidic device that mimics blood capillaries may help in early detection, and proper measures could reduce the risk of renal failures.

Through early classroom experiences, undergraduate education and advanced research training, women leaders are shaping a more inclusive and supportive scientific community.

Inositol phosphates are a family of small metabolites characterized by their different phosphorylation patterns. Inositol hexakisphosphate (IP6), the fully phosphorylated form of inositol phosphate, i...

Andrea Choe's company, Holoclara, has created an anti-inflammatory drug based on a molecule from worms.

Promising therapeutic candidate for steatosis. Unique lipid profiles in glycogen storage disease. Microglial lactic acid mediates neuroinflammation. Read about these recent papers.

March 26, 2025 | 12 p.m. Eastern

June 26–29, 2025 | Kansas City, Mo.

Meet Julia Zeitlinger and David Arnosti — two co-chairs of the ASBMB’s 2025 meeting on gene expression, to be held June 26-29, in Kansas City, Missouri.

UMass Chan Medical School is rescinding admission offers to candidates for its biomedical sciences PhD program over concerns about federal funding cuts.

Scientists aren’t always encouraged to be politically active. But recent political interference by the Trump administration has many fired up.